Drug profile · INN
hydrocortisone cypionate
CORTEF
hydrocortisone cypionate (CORTEF) is a glucocorticoid receptor agonist. Route of administration: oral. Current US regulatory status: approved.
Drug details — hydrocortisone cypionate
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 1
- Data quality
- 0.84
Quick answer
hydrocortisone cypionate (CORTEF) is a glucocorticoid receptor agonist. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Glucocorticoid receptor agonist
Primary target: Glucocorticoid receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is hydrocortisone cypionate?
hydrocortisone cypionate (CORTEF) is a glucocorticoid receptor agonist. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for hydrocortisone cypionate?
CORTEF is a marketed brand name for hydrocortisone cypionate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of hydrocortisone cypionate?
hydrocortisone cypionate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.